P1369: HDAC INHIBITION INVOLVES CD26 EXPRESSION ON MULTIPLE MYELOMA CELLS VIA THE C-MYC/SP1-MEDIATED PROMOTER ACTIVATION AND OVERCOMES THERAPEUTIC RESISTANCE BY HUMANIZED ANTIBODY
Hiroko Nishida,
Reiko Suzuki,
Kiyora Nakajima,
Chikao Morimoto,
Michiie Sakamoto
Affiliations
Hiroko Nishida
1 Keio University, School of Medicine, Pathology, Tokyo, Japan
Reiko Suzuki
2 Keio University, School of Medicine, Collaborative Research Resources, Tokyo, Jamaica
Kiyora Nakajima
1 Keio University, School of Medicine, Pathology, Tokyo, Japan
Chikao Morimoto
3 Juntendo University, Graduate School of Medicine, Therapy Development and Innovation for Immune Disorders and Cancers, Tokyo, Japan
Michiie Sakamoto
1 Keio University, School of Medicine, Pathology, Tokyo, Japan
